Centrifugation is essentially the most generally used technique for harvesting autotrophically produced microalgae, however it’s costly attributable to excessive power calls for. With the purpose of decreasing these prices, we examined electrocoagulation with iron electrodes for harvesting Chlorella vulgaris. Throughout in depth lab-scale experiments, the next components had been studied to realize a excessive harvesting effectivity and a low iron content material within the harvested biomass: electrical cost, preliminary biomass focus, pH, temperature, agitation depth, residual salt content material and electrolysis time. A harvesting effectivity larger than 95% was achieved over a broad vary of situations and the residual iron content material within the biomass complied with legislative necessities for meals. Utilizing electrocoagulation because the pre-concentration step previous to centrifugation, complete power prices had been decreased to 0.136 kWh/kg of dry biomass, which is lower than 14% of that for centrifugation alone. Our information present that electrocoagulation is an appropriate and cost-effective technique for harvesting microalgae.

Cyclic di-AMP is a bacterial nucleotide second messenger and evaluated as a possible vaccine adjuvant candidate. Right here, we report a sensible and economical enzymatic technique for gram-scale preparation of c-di-AMP utilizing an immobilized Vibrio cholerae dinucleotide cyclase DncV. The strategy primarily consists of 4 steps: preparation of DncV-immobilized resin, enzymatic synthesis of c-di-AMP, purification utilizing macroporous absorption resin SP207, and desiccation utilizing rotary evaporation and lyophilization. Enzymatic synthesis is essentially the most important step, and virtually all substrate ATP was transformed to c-di-AMP below an optimum situation during which 300 mL of 300 mM NH₄Ac/NH₃ pH 9.5 buffer supplemented with 20 mM MnCl₂, 10 mM ATP and Four mL of DncV-immobilized resin containing ∼19 mg DncV had been incubated at 30 °C in a single day.

After purification, as much as 1 g of the diammonium salt of c-di-AMP with weight purity of ≥98% was obtained as white powder, which corresponds to an total yield of ∼80% based mostly on the ATP enter into the response. The strategy is well carried out in laboratory to organize c-di-AMP on a gram scale and may very well be utilized in business on a big scale.

Northern peatlands sometimes develop by way of succession from fens dominated by the moss household Amblystegiaceae to bogs dominated by the moss genus Sphagnum. How the completely different crops and abiotic environmental situations offered in Amblystegiaceae and Sphagnum peat form the respective moss related microbial communities is unknown. Via a large-scale molecular and biogeochemical research spanning Arctic, sub-Arctic and temperate areas we assessed how the endo- and epiphytic microbial communities of pure northern peatland mosses relate to peatland kind (Sphagnum and Amblystegiaceae), location, moss taxa and abiotic environmental variables. Microbial range and neighborhood construction had been distinctly completely different between Amblystegiaceae and Sphagnum peatlands, and inside every of those two peatland sorts moss taxon defined the most important a part of microbial neighborhood variation.

Sphagnum and Amblystegiaceae shared few (< 1% of all operational taxonomic models (OTUs)) however strikingly plentiful (as much as 65% of relative abundance) OTUs. This core neighborhood overlapped by one third with the Sphagnum-specific core-community. Thus, essentially the most plentiful microorganisms in Sphagnum which might be additionally present in all of the Sphagnum crops studied, are the identical OTUs as these few shared with Amblystegiaceae. Lastly, we might verify that these extremely plentiful OTUs had been endophytes in Sphagnum, however epiphytes on Amblystegiaceae.

Phospho-STAT6 (Tyr641) Blocking Peptide
AF3301-BP	1mg	EUR 234

Phospho-STAT6 (Thr645) Blocking Peptide
AF3302-BP	1mg	EUR 234

Human Signal Transducer And Activator Of Transcription 6 (STAT6) ELISA Kit
DLR-STAT6-Hu-48T	48T	EUR 597.6
Description: A sandwich quantitative ELISA assay kit for detection of Human Signal Transducer And Activator Of Transcription 6 (STAT6) in samples from tissue homogenates or other biological fluids.

Human Signal Transducer And Activator Of Transcription 6 (STAT6) ELISA Kit
DLR-STAT6-Hu-96T	96T	EUR 776.4
Description: A sandwich quantitative ELISA assay kit for detection of Human Signal Transducer And Activator Of Transcription 6 (STAT6) in samples from tissue homogenates or other biological fluids.

Rat Signal Transducer And Activator Of Transcription 6 (STAT6) ELISA Kit
DLR-STAT6-Ra-48T	48T	EUR 633.6
Description: A sandwich quantitative ELISA assay kit for detection of Rat Signal Transducer And Activator Of Transcription 6 (STAT6) in samples from serum, plasma, tissue homogenates or other biological fluids.

Rat Signal Transducer And Activator Of Transcription 6 (STAT6) ELISA Kit
DLR-STAT6-Ra-96T	96T	EUR 828
Description: A sandwich quantitative ELISA assay kit for detection of Rat Signal Transducer And Activator Of Transcription 6 (STAT6) in samples from serum, plasma, tissue homogenates or other biological fluids.

Human Signal Transducer And Activator Of Transcription 6 (STAT6) ELISA Kit
RD-STAT6-Hu-48Tests	48 Tests	EUR 600

Human Signal Transducer And Activator Of Transcription 6 (STAT6) ELISA Kit
RD-STAT6-Hu-96Tests	96 Tests	EUR 830.4

Rat Signal Transducer And Activator Of Transcription 6 (STAT6) ELISA Kit
RD-STAT6-Ra-48Tests	48 Tests	EUR 640.8

Rat Signal Transducer And Activator Of Transcription 6 (STAT6) ELISA Kit
RD-STAT6-Ra-96Tests	96 Tests	EUR 890.4

Human Signal Transducer And Activator Of Transcription 6 (STAT6) ELISA Kit
RDR-STAT6-Hu-48Tests	48 Tests	EUR 626.4

Human Signal Transducer And Activator Of Transcription 6 (STAT6) ELISA Kit
RDR-STAT6-Hu-96Tests	96 Tests	EUR 868.8

Rat Signal Transducer And Activator Of Transcription 6 (STAT6) ELISA Kit
RDR-STAT6-Ra-48Tests	48 Tests	EUR 669.6

Rat Signal Transducer And Activator Of Transcription 6 (STAT6) ELISA Kit
RDR-STAT6-Ra-96Tests	96 Tests	EUR 931.2

Substance P reversed sequence Peptide
20-abx266314	EUR 594.00 EUR 978.00 EUR 427.20	10 mg 25 mg 5 mg

Erythropoietin Mimetic Peptide Sequence 20
H-4344.0001	1.0mg	EUR 544.8
Description: Sum Formula: C72H99N17O17S2; CAS# [203397-62-0] net

Erythropoietin Mimetic Peptide Sequence 20
H-4344.0005	5.0mg	EUR 2067.6
Description: Sum Formula: C72H99N17O17S2; CAS# [203397-62-0] net

(NANP)5 peptide (repeat-sequence peptide of the P. falciparum circumsporozoite protein, CSP) control/blocking peptide
NANP51-P	1 mg	EUR 416.4

(PPPPNAND)3 peptide (repeat-sequence peptide of the P. berghei circumsporozoite protein, CSP) control/blocking peptide
PPPP321-P	100 ug	EUR 196.8

(NVDP)4 peptide (minor repeat-sequence peptide of the P. falciparum circumsporozoite protein, CSP) control/blocking peptide
NVDP41-P	100 ug	EUR 196.8

Influenza A virus (H5N1) matrix protein 2 hybrid sequence Control/blocking peptide
M2E11-P	100 ug	EUR 196.8

(DRAAGQPAG)3 (repeat-sequence peptide of the P. vivax circumsporozoite protein, CSP) control/blocking peptide
DRAA31-P	100 ug	EUR 196.8

C-Peptide Blocking Peptide
3277BP-50	each	EUR 183.6

STAT6 antibody
70R-11851	100 ug	EUR 483.6
Description: Rabbit polyclonal STAT6 antibody

STAT6 antibody
70R-37490	100 ug	EUR 327.6
Description: Rabbit Polyclonal STAT6 antibody

STAT6 antibody
70R-37491	100 ug	EUR 327.6
Description: Rabbit Polyclonal STAT6 antibody

STAT6 antibody
70R-50438	100 ul	EUR 292.8
Description: Purified Polyclonal STAT6 antibody

STAT6 antibody
70R-20577	50 ul	EUR 522
Description: Rabbit polyclonal STAT6 antibody

STAT6 antibody
70R-32523	100 ug	EUR 392.4
Description: Rabbit polyclonal STAT6 antibody

STAT6 antibody
70R-32525	100 ug	EUR 392.4
Description: Rabbit polyclonal STAT6 antibody

STAT6 antibody
70R-14225	100 ug	EUR 386.4
Description: Affinity purified Rabbit polyclonal STAT6 antibody

STAT6 antibody
70R-14228	100 ug	EUR 386.4
Description: Affinity purified Rabbit polyclonal STAT6 antibody

STAT6 antibody
70R-51645	100 ul	EUR 344.4
Description: Purified Polyclonal STAT6 antibody

STAT6 Antibody
48579-100ul	100ul	EUR 399.6

STAT6 Antibody
48579-50ul	50ul	EUR 286.8

STAT6 Antibody
48733-100ul	100ul	EUR 399.6

STAT6 Antibody
48733-50ul	50ul	EUR 286.8

STAT6 Antibody
48795-100ul	100ul	EUR 399.6

STAT6 Antibody
48795-50ul	50ul	EUR 286.8

STAT6 Antibody
35574-100ul	100ul	EUR 302.4

STAT6 antibody
10R-1225	100 ug	EUR 614.4
Description: Mouse monoclonal STAT6 antibody

Stat6 antibody
20R-1596	100 ug	EUR 807.6
Description: Rabbit polyclonal Stat6 antibody

Stat6 antibody
20R-1599	100 ug	EUR 846
Description: Rabbit polyclonal Stat6 antibody

STAT6 antibody
20R-1916	50 ug	EUR 337.2
Description: Rabbit polyclonal STAT6 antibody

STAT6 antibody
20R-1917	50 ug	EUR 337.2
Description: Rabbit polyclonal STAT6 antibody

STAT6 antibody
20R-2232	50 ug	EUR 337.2
Description: Rabbit polyclonal STAT6 antibody

STAT6 antibody
20R-2233	50 ug	EUR 337.2
Description: Rabbit polyclonal STAT6 antibody

STAT6 antibody
10R-2207	100 ul	EUR 483.6
Description: Mouse monoclonal STAT6 antibody

STAT6 antibody
10R-3083	100 ug	EUR 488.4
Description: Mouse monoclonal STAT6 antibody

STAT6 antibody
10R-3084	100 ug	EUR 488.4
Description: Mouse monoclonal STAT6 antibody

STAT6 antibody
10R-3085	100 ug	EUR 488.4
Description: Mouse monoclonal STAT6 antibody

STAT6 Antibody
ABF6301	100 ug	EUR 525.6

STAT6 Antibody
ABF6302	100 ug	EUR 525.6

STAT6 siRNA
20-abx935416	EUR 661.20 EUR 878.40	15 nmol 30 nmol

STAT6 siRNA
20-abx935417	EUR 661.20 EUR 878.40	15 nmol 30 nmol

STAT6 antibody
70R-7858	50 ug	EUR 560.4
Description: Affinity purified rabbit polyclonal STAT6 antibody

STAT6 Antibody
1-CSB-PA050171	EUR 266.40 EUR 234.00	100ug 50ug
Description: A polyclonal antibody against STAT6. Recognizes STAT6 from Human, Mouse, Rat, Monkey. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/5000

STAT6 Antibody
AF6301	200ul	EUR 420

STAT6 Antibody
AF6302	200ul	EUR 420

STAT6 Antibody
1-CSB-PA171110	EUR 380.40 EUR 292.80	100ul 50ul
Description: A polyclonal antibody against STAT6. Recognizes STAT6 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;ELISA:1:2000-1:5000, WB:1:500-1:2000

STAT6 Antibody
1-CSB-PA138665	EUR 380.40 EUR 292.80	100ul 50ul
Description: A polyclonal antibody against STAT6. Recognizes STAT6 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;ELISA:1:2000-1:5000, WB:1:500-1:2000

STAT6 Antibody
1-CSB-PA022816GA01HU	EUR 716.40 EUR 399.60	150ul 50ul
Description: A polyclonal antibody against STAT6. Recognizes STAT6 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC

STAT6 Antibody
1-CSB-PA022816LA01HU	EUR 380.40 EUR 402.00	100ug 50ug
Description: A polyclonal antibody against STAT6. Recognizes STAT6 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200

STAT6 Antibody
1-CSB-PA004183	EUR 266.40 EUR 234.00	100ug 50ug
Description: A polyclonal antibody against STAT6. Recognizes STAT6 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, IP, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IP:2-5ug/mglysate.ELISA:1/20000

STAT6 protein
E20-80110	20ug	EUR 489.6

anti-STAT6
YF-PA24783	50 ul	EUR 400.8
Description: Mouse polyclonal to STAT6

anti-STAT6
YF-PA14823	50 ul	EUR 435.6
Description: Mouse polyclonal to STAT6

anti-STAT6
YF-PA14824	50 ug	EUR 435.6
Description: Mouse polyclonal to STAT6

anti-STAT6
YF-PA14825	100 ug	EUR 483.6
Description: Rabbit polyclonal to STAT6

anti-STAT6
YF-PA27371	100 ul	EUR 483.6
Description: Rabbit polyclonal to STAT6

STAT6 Antibody
R32096	100 ug	EUR 419

Stat6 Antibody
3473R-100	each	EUR 379.2

Stat6 Antibody
3473R-30T	each	EUR 175.2

STAT6 Antibody
V3893-100UG	100 ug	EUR 499
Description: STAT6 is a transcription factor in the Jak/STAT signal transduction pathway responsible for mediating IL-4 immune signaling. STAT6 was recently suggested to be a reliable marker to distinguish solitary fibrous tumors from other soft tissue neoplasms. Gene fusions are common in solitary fibrous tumors. Recent next generation sequencing studies demonstrated the presence of a NAB2-STAT6 fusion, formed by an intrachromosomal inversion fusing two neighboring genes on chromosome 12q13, in 55-100% of solitary fibrous tumors, regardless of tumor morphology or anatomical site. By immunohistochemistry, nuclear STAT6 expression can discriminate solitary fibrous tumors from its morphological mimics in the meninges, including meningioma, glioblastoma, gliosarcoma, haemangioblastoma, schwannoma and haemangioma. A recent study by Cheah, et al. using the rabbit monoclonal STAT6 antibody (Clone YE361) observed expression in all solitary fibrous tumors (54/54) tested, regardless of histology, anatomical site or CD34 status. Morphological mimics of solitary fibrous tumors were negative, demonstrating 100% specificity.

STAT6 Antibody
V3893-20UG	20 ug	EUR 219
Description: STAT6 is a transcription factor in the Jak/STAT signal transduction pathway responsible for mediating IL-4 immune signaling. STAT6 was recently suggested to be a reliable marker to distinguish solitary fibrous tumors from other soft tissue neoplasms. Gene fusions are common in solitary fibrous tumors. Recent next generation sequencing studies demonstrated the presence of a NAB2-STAT6 fusion, formed by an intrachromosomal inversion fusing two neighboring genes on chromosome 12q13, in 55-100% of solitary fibrous tumors, regardless of tumor morphology or anatomical site. By immunohistochemistry, nuclear STAT6 expression can discriminate solitary fibrous tumors from its morphological mimics in the meninges, including meningioma, glioblastoma, gliosarcoma, haemangioblastoma, schwannoma and haemangioma. A recent study by Cheah, et al. using the rabbit monoclonal STAT6 antibody (Clone YE361) observed expression in all solitary fibrous tumors (54/54) tested, regardless of histology, anatomical site or CD34 status. Morphological mimics of solitary fibrous tumors were negative, demonstrating 100% specificity.

STAT6 Antibody
V3893SAF-100UG	100 ug	EUR 499
Description: STAT6 is a transcription factor in the Jak/STAT signal transduction pathway responsible for mediating IL-4 immune signaling. STAT6 was recently suggested to be a reliable marker to distinguish solitary fibrous tumors from other soft tissue neoplasms. Gene fusions are common in solitary fibrous tumors. Recent next generation sequencing studies demonstrated the presence of a NAB2-STAT6 fusion, formed by an intrachromosomal inversion fusing two neighboring genes on chromosome 12q13, in 55-100% of solitary fibrous tumors, regardless of tumor morphology or anatomical site. By immunohistochemistry, nuclear STAT6 expression can discriminate solitary fibrous tumors from its morphological mimics in the meninges, including meningioma, glioblastoma, gliosarcoma, haemangioblastoma, schwannoma and haemangioma. A recent study by Cheah, et al. using the rabbit monoclonal STAT6 antibody (Clone YE361) observed expression in all solitary fibrous tumors (54/54) tested, regardless of histology, anatomical site or CD34 status. Morphological mimics of solitary fibrous tumors were negative, demonstrating 100% specificity.

STAT6 Antibody
RQ5923	100 ug	EUR 419

STAT6 Antibody
V4052-100UG	100 ug	EUR 349.3
Description: STAT6 is a transcription factor in the Jak/STAT signal transduction pathway responsible for mediating IL-4 immune signaling. STAT6 was recently suggested to be a reliable marker to distinguish solitary fibrous tumors from other soft tissue neoplasms. Gene fusions are common in solitary fibrous tumors. Recent next generation sequencing studies demonstrated the presence of a NAB2-STAT6 fusion, formed by an intrachromosomal inversion fusing two neighboring genes on chromosome 12q13, in 55-100% of solitary fibrous tumors, regardless of tumor morphology or anatomical site. By immunohistochemistry, nuclear STAT6 expression can discriminate solitary fibrous tumors from its morphological mimics in the meninges, including meningioma, glioblastoma, gliosarcoma, haemangioblastoma, schwannoma and haemangioma. A recent study by Cheah, et al. using the rabbit monoclonal STAT6 antibody (Clone YE361) observed expression in all solitary fibrous tumors (54/54) tested, regardless of histology, anatomical site or CD34 status. Morphological mimics of solitary fibrous tumors were negative, demonstrating 100% specificity.

STAT6 Antibody
V4052-20UG	20 ug	EUR 153.3
Description: STAT6 is a transcription factor in the Jak/STAT signal transduction pathway responsible for mediating IL-4 immune signaling. STAT6 was recently suggested to be a reliable marker to distinguish solitary fibrous tumors from other soft tissue neoplasms. Gene fusions are common in solitary fibrous tumors. Recent next generation sequencing studies demonstrated the presence of a NAB2-STAT6 fusion, formed by an intrachromosomal inversion fusing two neighboring genes on chromosome 12q13, in 55-100% of solitary fibrous tumors, regardless of tumor morphology or anatomical site. By immunohistochemistry, nuclear STAT6 expression can discriminate solitary fibrous tumors from its morphological mimics in the meninges, including meningioma, glioblastoma, gliosarcoma, haemangioblastoma, schwannoma and haemangioma. A recent study by Cheah, et al. using the rabbit monoclonal STAT6 antibody (Clone YE361) observed expression in all solitary fibrous tumors (54/54) tested, regardless of histology, anatomical site or CD34 status. Morphological mimics of solitary fibrous tumors were negative, demonstrating 100% specificity.

STAT6 Antibody
V4052SAF-100UG	100 ug	EUR 349.3
Description: STAT6 is a transcription factor in the Jak/STAT signal transduction pathway responsible for mediating IL-4 immune signaling. STAT6 was recently suggested to be a reliable marker to distinguish solitary fibrous tumors from other soft tissue neoplasms. Gene fusions are common in solitary fibrous tumors. Recent next generation sequencing studies demonstrated the presence of a NAB2-STAT6 fusion, formed by an intrachromosomal inversion fusing two neighboring genes on chromosome 12q13, in 55-100% of solitary fibrous tumors, regardless of tumor morphology or anatomical site. By immunohistochemistry, nuclear STAT6 expression can discriminate solitary fibrous tumors from its morphological mimics in the meninges, including meningioma, glioblastoma, gliosarcoma, haemangioblastoma, schwannoma and haemangioma. A recent study by Cheah, et al. using the rabbit monoclonal STAT6 antibody (Clone YE361) observed expression in all solitary fibrous tumors (54/54) tested, regardless of histology, anatomical site or CD34 status. Morphological mimics of solitary fibrous tumors were negative, demonstrating 100% specificity.

Hsp70 Blocking Peptide
33R-10632	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Hsp70 antibody, catalog no. 70R-11611

SIRT7 Blocking Peptide
33R-10633	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SIRT7 antibody, catalog no. 70R-11612

MAPKAPK2 Blocking Peptide
33R-10634	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of MAPKAPK2 antibody, catalog no. 70R-11613

CD339 Blocking Peptide
33R-10635	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CD339 antibody, catalog no. 70R-11614

PKA Blocking Peptide
33R-10637	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PKA antibody, catalog no. 70R-11621

Raf1 Blocking Peptide
33R-10638	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Raf1 antibody, catalog no. 70R-11622

Wee1 Blocking Peptide
33R-10639	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Wee1 antibody, catalog no. 70R-11626

IHH Blocking Peptide
33R-1064	100 ug	EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SLC26A1 antibody, catalog no. 70R-6562

GSTP1 Blocking Peptide
33R-10640	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GSTP1 antibody, catalog no. 70R-11628

TNFR1 Blocking Peptide
33R-10641	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TNFR1 antibody, catalog no. 70R-11629

LSD1 Blocking Peptide
33R-10642	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of LSD1 antibody, catalog no. 70R-11631

STAT1 Blocking Peptide
33R-10643	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of STAT1 antibody, catalog no. 70R-11633

MAK10 Blocking Peptide
33R-10644	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of MAK10 antibody, catalog no. 70R-11634

ACADM Blocking Peptide
33R-10647	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ACADM antibody, catalog no. 70R-11637

ACADL Blocking Peptide
33R-10649	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ACADL antibody, catalog no. 70R-11639

SLC26A1 Blocking Peptide
33R-1065	100 ug	EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CACNB2 antibody, catalog no. 70R-1508

ACADSB Blocking Peptide
33R-10650	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ACADSB antibody, catalog no. 70R-11649

ACADSB Blocking Peptide
33R-10651	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ACADSB antibody, catalog no. 70R-11656

Survivin Blocking Peptide
33R-10653	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Survivin antibody, catalog no. 70R-11659

Bid Blocking Peptide
33R-10654	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Bid antibody, catalog no. 70R-11670

CD40L Blocking Peptide
33R-10655	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CD40L antibody, catalog no. 70R-11674

cIAP1 Blocking Peptide
33R-10656	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of cIAP1 antibody, catalog no. 70R-11676

cIAP1 Blocking Peptide
33R-10657	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of cIAP1 antibody, catalog no. 70R-11675

cIAP2 Blocking Peptide
33R-10658	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of cIAP2 antibody, catalog no. 70R-11677

XIAP Blocking Peptide
33R-10659	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of XIAP antibody, catalog no. 70R-11678

CACNB2 Blocking Peptide
33R-1066	100 ug	EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of LHPP antibody, catalog no. 70R-4027

Perforin Blocking Peptide
33R-10660	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Perforin antibody, catalog no. 70R-11680

NIK Blocking Peptide
33R-10665	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of NIK antibody, catalog no. 70R-11685

TrkA Blocking Peptide
33R-10666	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TrkA antibody, catalog no. 70R-11686

AIF Blocking Peptide
33R-10667	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of AIF antibody, catalog no. 70R-11690

DR6 Blocking Peptide
33R-10668	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of DR6 antibody, catalog no. 70R-11695

SIRT3 Blocking Peptide
33R-10669	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SIRT3 antibody, catalog no. 70R-11698

LHPP Blocking Peptide
33R-1067	100 ug	EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of UPP1 antibody, catalog no. 70R-3171

SIRT4 Blocking Peptide
33R-10670	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SIRT4 antibody, catalog no. 70R-11699

SIRT5 Blocking Peptide
33R-10671	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SIRT5 antibody, catalog no. 70R-11700

NAIP Blocking Peptide
33R-10672	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of NAIP antibody, catalog no. 70R-11701

MBD2a Blocking Peptide
33R-10673	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of MBD2a antibody, catalog no. 70R-11702

SALL1 Blocking Peptide
33R-10674	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SALL1 antibody, catalog no. 70R-11703

SIAH3 Blocking Peptide
33R-10675	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SIAH3 antibody, catalog no. 70R-11704

ACAD9 Blocking Peptide
33R-10676	50 ug	EUR 229.2
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ACAD9 antibody, catalog no. 70R-11705

We conclude that moss taxa and abiotic environmental variables affiliate with explicit microbial communities. Whereas moss taxon was essentially the most influential parameter, hydrology, pH and temperature additionally had important results on the microbial communities. A small although extremely plentiful core neighborhood is shared between Sphagnum and Amblystegiaceae.